Brunei News Gazette

Category: Press Releases

DayOne Data Centers Appoints Greg Norman as Board Advisor as It Expands Its Global Digital Infrastructure Platform

Greg Norman, DayOne Board Advisor SINGAPORE, Feb. 11, 2026 (GLOBE NEWSWIRE) — DayOne Data Centers Limited (“DayOne”), a Singapore-headquartered global hyperscale data center platform, announced on February 10 the appointment of Greg Norman as a Board Advisor, supporting DayOne’s long-term strategy for global expansion and sustainable growth across Asia-Pacific and Europe. Widely recognized for his […]

February 11, 2026

DayOne Data Centers Appoints Greg Norman as Board Advisor as It Expands Its Global Digital Infrastructure Platform

Greg Norman, DayOne Board Advisor SINGAPORE, Feb. 11, 2026 (GLOBE NEWSWIRE) — DayOne Data Centers Limited (“DayOne”), a Singapore-headquartered global hyperscale data center platform, announced on February 10 the appointment of Greg Norman as a Board Advisor, supporting DayOne’s long-term strategy for global expansion and sustainable growth across Asia-Pacific and Europe. Widely recognized for his […]

February 11, 2026

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed as Helus Pharma advances its […]

February 10, 2026

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed as Helus Pharma advances its […]

February 10, 2026

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed as Helus Pharma advances its […]

February 10, 2026

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed as Helus Pharma advances its […]

February 10, 2026

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed as Helus Pharma advances its […]

February 10, 2026

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed as Helus Pharma advances its […]

February 10, 2026

NetBox Labs Announces General Availability of NetBox Copilot, Delivering Enterprise-Ready AI Grounded in Accurate Infrastructure Data

NetBox Copilot accelerates operations and automation, while providing self-service to non-IT teams NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) — Today, NetBox Labs, the central nervous system for networks and infrastructure, announced the general availability of NetBox Copilot, an interactive AI agent embedded directly into the NetBox platform. As AI agents rapidly move from experimentation into […]

February 10, 2026

NetBox Labs Announces General Availability of NetBox Copilot, Delivering Enterprise-Ready AI Grounded in Accurate Infrastructure Data

NetBox Copilot accelerates operations and automation, while providing self-service to non-IT teams NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) — Today, NetBox Labs, the central nervous system for networks and infrastructure, announced the general availability of NetBox Copilot, an interactive AI agent embedded directly into the NetBox platform. As AI agents rapidly move from experimentation into […]

February 10, 2026

newsletter

Recent news